COMMUNIQUÉS West-GlobeNewswire

-
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial
02/06/2025 -
The Worsening Pandemic of Gambling Highlighted in the Journal of American Physicians and Surgeons
02/06/2025 -
‘Stealthy’ Endocrine Effects of the COVID Vaccine Discussed in the Journal of American Physicians and Surgeons
02/06/2025 -
Elite Clinical Network Appoints Christopher Brennan as Chief Executive Officer
02/06/2025 -
DentPrime Signs New Sponsorship Agreement with Czech Republic's Renowned Ice Hockey Team Orli Znojmo
02/06/2025 -
OSE Immunotherapeutics Provides Clinical Updates on Neo-Epitope Based Cancer Vaccine Tedopi® in Pancreatic Cancer and Non-Small Cell Lung Cancer
02/06/2025 -
OSE Immunotherapeutics fait un point clinique sur Tedopi®, vaccin contre le cancer à base de néo-épitopes, dans le cancer du pancréas et dans le cancer du poumon non à petites cellules
02/06/2025 -
HOOPP appoints Reena Carter as new Chief Financial Officer
02/06/2025 -
4D Path Presents Breakthrough Research Demonstrating That Its Unique Digital Predictive Biomarker Identifies Treatment Responders in a Difficult-To-Treat Breast Cancer Patient Population
02/06/2025 -
Civitas Networks for Health Opens Registration for 2025 Annual Conference
02/06/2025 -
Vantive to Invest More Than $1 Billion in Advancing Kidney Care and Vital Organ Support Through Digitally-Enabled Therapies
02/06/2025 -
Precede Biosciences Presents ASCO 2025 Data Highlighting the Ability of its Liquid Biopsy Platform to Reveal the Biology Underlying Response and Resistance to ADCs and Radiopharmaceuticals
02/06/2025 -
Wildfire Smoke is Already Suffocating Canada – Here’s How to Save Your Lungs
02/06/2025 -
MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients
02/06/2025 -
The Journal of Clinical Oncology Publishes Five-year Analysis of Amtagvi® (lifileucel) in Patients with Advanced Melanoma
02/06/2025 -
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
02/06/2025 -
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
02/06/2025 -
Cytrellis Strengthens Leadership Team in Support of Accelerated Commercial Growth of ellacor® Platform
02/06/2025 -
Evosep unveils new instrumentation and partnership at ASMS 2025
02/06/2025
Pages